# Efficacy of Novel Drug-combinations for Relief of Psoriasis

> **NCT02394301** · — · SUSPENDED · sponsor: **Medimix Specialty Pharmacy, LLC** · enrollment: 200 (estimated)

## Conditions studied

- Psoriasis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02394301
- **Lead sponsor:** Medimix Specialty Pharmacy, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2015-02
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 200 (ESTIMATED)
- **Why stopped:** Poor enrollment
- **Last updated:** 2015-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02394301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02394301, "Efficacy of Novel Drug-combinations for Relief of Psoriasis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02394301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*